Linyu Wu
State Key Laboratory Of Oncology In South China, No. 651 Dongfengdong, Yuexiu District
Guangzhou, 510000, China
Guangzhou, 510000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study.
Journal: Journal of cancer research and clinical oncology
Published: June 16, 2026
Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study.
Journal: Journal of cancer research and clinical oncology
Published: January 28, 2026
ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer.
Journal: Journal of advanced research
Published: June 05, 2025
Immediate lymphatic reconstruction (ILR) for prevention of secondary lymphedema after breast cancer surgery: a systematic review and meta‑analysis.
Journal: Gland surgery
Published: February 01, 2025
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer.
Journal: Journal of advanced research
Published: December 04, 2023
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer.
Journal: Cell death discovery
Published: February 28, 2023
Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration.
Journal: International journal of biological sciences
Published: December 17, 2022
AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer.
Journal: Cell death & disease
Published: October 02, 2022
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 26, 2022
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Journal: International journal of surgery (London, England)
Published: April 08, 2022
Last Updated: 09/26/2026